Total words: 1540 | 2-word phrases: 400 | 3-word phrases: 449 | 4-word phrases: 469
PAGE INFO
Title | Try to keep the title under 60 characters (27 characters) ..:: The Drug Database ::.. |
Description | Try to keep the meta description between 50 - 160 characters (0 characters) |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (37 characters) The drug database for acute porphyria |
ONE WORD PHRASES 222 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | the | | | | | | | 33 | 14.86% |
2 | of | | | | | | | 20 | 9.01% |
3 | porphyria | | | | | | | 16 | 7.21% |
4 | for | | | | | | | 13 | 5.86% |
5 | to | | | | | | | 13 | 5.86% |
6 | website | | | | | | | 11 | 4.95% |
7 | this | | | | | | | 10 | 4.50% |
8 | and | | | | | | | 9 | 4.05% |
9 | napos | | | | | | | 9 | 4.05% |
10 | in | | | | | | | 9 | 4.05% |
TWO WORD PHRASES 400 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | of the | | | | | | | 8 | 2.00% |
2 | this website | | | | | | | 8 | 2.00% |
3 | acute porphyria | | | | | | | 6 | 1.50% |
4 | the drug | | | | | | | 5 | 1.25% |
5 | drug database | | | | | | | 5 | 1.25% |
6 | database for | | | | | | | 5 | 1.25% |
7 | norwegian porphyria | | | | | | | 5 | 1.25% |
8 | porphyria centre | | | | | | | 5 | 1.25% |
9 | to the | | | | | | | 4 | 1.00% |
10 | centre napos | | | | | | | 4 | 1.00% |
11 | the information | | | | | | | 4 | 1.00% |
12 | for acute | | | | | | | 4 | 1.00% |
13 | terms of | | | | | | | 3 | 0.75% |
14 | on this | | | | | | | 3 | 0.75% |
15 | healthcare professionals | | | | | | | 3 | 0.75% |
16 | use of | | | | | | | 3 | 0.75% |
17 | may be | | | | | | | 3 | 0.75% |
18 | the norwegian | | | | | | | 3 | 0.75% |
19 | for any | | | | | | | 3 | 0.75% |
20 | of use | | | | | | | 3 | 0.75% |
THREE WORD PHRASES 449 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | the drug database | | | | | | | 5 | 1.11% |
2 | drug database for | | | | | | | 5 | 1.11% |
3 | norwegian porphyria centre | | | | | | | 5 | 1.11% |
4 | database for acute | | | | | | | 4 | 0.89% |
5 | for acute porphyria | | | | | | | 4 | 0.89% |
6 | porphyria centre napos | | | | | | | 4 | 0.89% |
7 | the norwegian porphyria | | | | | | | 3 | 0.67% |
8 | on this website | | | | | | | 3 | 0.67% |
9 | the use of | | | | | | | 3 | 0.67% |
10 | terms of use | | | | | | | 3 | 0.67% |
11 | from this website | | | | | | | 2 | 0.45% |
12 | in this database | | | | | | | 2 | 0.45% |
13 | not be liable | | | | | | | 2 | 0.45% |
14 | data from this | | | | | | | 2 | 0.45% |
15 | liable for any | | | | | | | 2 | 0.45% |
16 | be liable for | | | | | | | 2 | 0.45% |
17 | will not be | | | | | | | 2 | 0.45% |
18 | subject to change | | | | | | | 2 | 0.45% |
19 | of the norwegian | | | | | | | 2 | 0.45% |
20 | this website is | | | | | | | 2 | 0.45% |
21 | using this website | | | | | | | 2 | 0.45% |
22 | by using this | | | | | | | 2 | 0.45% |
23 | andor damages in | | | | | | | 1 | 0.22% |
24 | efforts are made | | | | | | | 1 | 0.22% |
25 | while efforts are | | | | | | | 1 | 0.22% |
26 | acute porphyria 5 | | | | | | | 1 | 0.22% |
27 | the the drug | | | | | | | 1 | 0.22% |
28 | of the the | | | | | | | 1 | 0.22% |
29 | use of the | | | | | | | 1 | 0.22% |
30 | with the use | | | | | | | 1 | 0.22% |
FOUR WORD PHRASES 469 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | the drug database for | | | | | | | 5 | 1.07% |
2 | database for acute porphyria | | | | | | | 4 | 0.85% |
3 | drug database for acute | | | | | | | 4 | 0.85% |
4 | norwegian porphyria centre napos | | | | | | | 4 | 0.85% |
5 | the norwegian porphyria centre | | | | | | | 3 | 0.64% |
6 | not be liable for | | | | | | | 2 | 0.43% |
7 | be liable for any | | | | | | | 2 | 0.43% |
8 | of the norwegian porphyria | | | | | | | 2 | 0.43% |
9 | by using this website | | | | | | | 2 | 0.43% |
10 | on this website is | | | | | | | 2 | 0.43% |
11 | will not be liable | | | | | | | 2 | 0.43% |
12 | data from this website | | | | | | | 2 | 0.43% |
13 | any losses andor damages | | | | | | | 1 | 0.21% |
14 | of the the drug | | | | | | | 1 | 0.21% |
15 | use of the the | | | | | | | 1 | 0.21% |
16 | the use of the | | | | | | | 1 | 0.21% |
17 | with the use of | | | | | | | 1 | 0.21% |
18 | connection with the use | | | | | | | 1 | 0.21% |
19 | losses andor damages in | | | | | | | 1 | 0.21% |
20 | for any losses andor | | | | | | | 1 | 0.21% |
21 | napos will not be | | | | | | | 1 | 0.21% |
22 | liable for any losses | | | | | | | 1 | 0.21% |
23 | website is strictly at | | | | | | | 1 | 0.21% |
24 | is strictly at their | | | | | | | 1 | 0.21% |
25 | own risk 4 napos | | | | | | | 1 | 0.21% |
26 | risk 4 napos will | | | | | | | 1 | 0.21% |
27 | 4 napos will not | | | | | | | 1 | 0.21% |
28 | the the drug database | | | | | | | 1 | 0.21% |
29 | while efforts are made | | | | | | | 1 | 0.21% |
30 | for acute porphyria 5 | | | | | | | 1 | 0.21% |
31 | liable for any temporary | | | | | | | 1 | 0.21% |
32 | use of data from | | | | | | | 1 | 0.21% |
33 | the use of data | | | | | | | 1 | 0.21% |
34 | on the use of | | | | | | | 1 | 0.21% |
35 | limitations on the use | | | | | | | 1 | 0.21% |
36 | beyond our control 6 | | | | | | | 1 | 0.21% |
37 | issues beyond our control | | | | | | | 1 | 0.21% |
38 | technical issues beyond our | | | | | | | 1 | 0.21% |
39 | to technical issues beyond | | | | | | | 1 | 0.21% |
40 | due to technical issues | | | | | | | 1 | 0.21% |
EXTERNAL LINKS